The stock market is down Monday, with the Dow Jones Industrial Average down 0.20%, the Nasdaq down 0.04% and the S&P 500 down 0.39%. Today’s sole winner is a pharmaceutical company with a kidney drug that passed a trial, and today’s sole loser announced that its yearly profit will fall short of prior estimates.
This is today’s market winner and loser.
Biggest Winner
Shares of Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) are up 41.40% to $4.85 on trading volume of 10.7 million shares. A kidney disease drug the company is trying to get on the market has passed a late-stage trial. The 52-week high is $5.19.
Biggest Loser
Shares of Jos. A Bank Clothiers Inc. (NASDAQ: JOSB) are down 16.25% to $38.75 on trading volume of 1.7 million shares. The company announced that 2012 profit will fall 20% compared to the prior year because of warmer-than-usual weather and U.S. political unease. Before Monday, the 52-week low was $39.54.
Follow Samuel on Twitter: SWeigley
In 20 Years, I Haven’t Seen A Cash Back Card This Good
After two decades of reviewing financial products I haven’t seen anything like this. Credit card companies are at war, handing out free rewards and benefits to win the best customers.
A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges.
Our top pick today pays up to 5% cash back, a $200 bonus on top, and $0 annual fee. Click here to apply before they stop offering rewards this generous.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.